MS Hope Foundation

Been hearing about “ECTRIMS” but not sure what it means? Here’s why it’s important.

ECTRIMS, or the European Committee for Treatment and Research in Multiple Sclerosis, is a European organization whose mission is to bring the world’s top MS professionals together for the benefit of people affected by MS. The ECTRIMS website states that “the ultimate goal of ECTRIMS is to improve basic and clinical research and clinical outcomes in MS.” Sounds good — and they’re meeting right now!

The 32nd annual congress of ECTRIMS began on Wednesday September 14th, 2016 in London, England and will run through September 17th. Because we’re such a small organization, we weren’t able to hop across the pond and attend, but we’re following the best ECTRIMS 2016 coverage and will do our best to share the latest from London right here. Here are the hottest headlines from Multiple Sclerosis News Today, MD Magazine, and ShiftMS.

Antioxidant Lipoic Acid Appears to Slow SPMS Patients’ Neurodegeneration
via Multiple Sclerosis News Today

Modeling Approach Able to Identify Likely Disease Trajectory in Progressive MS Patients
via Multiple Sclerosis News Today

Siponimod Significantly Reduces Disability Progression Risk in SPMS
via MD Magazine

Inflammatory Profiles of Brain Seen to Predict MS Disability
via Multiple Sclerosis News Today

MS Patients May Be at Lower Risk for Other Illnesses, Danish Study Suggests
via Multiple Sclerosis News Today

Vitamin D Deficiency Linked to Higher Risk of MS for Women in Finland
via Multiple Sclerosis News Today

Sanofi Releases Patients’ Views of Aubagio as Effective Treatment for Relapsing MS
via Multiple Sclerosis News Today

Inflammatory Profiles of Brain Seen to Predict MS Disability
via Multiple Sclerosis News Today

Protein Seen as New Target in Preventing Brain Inflammation in MS
via Multiple Sclerosis News Today

Young Investigator Explains New MRI Criteria for MS Diagnosis in Patients with CIS
via News Medical

Researchers Disagree on Feasibility of MS Bone Marrow Transplants
via Multiple Sclerosis News Today

MS Patients’ Perceptions of Exercise Key to Their Participation
via Multiple Sclerosis News Today

Eye Imaging Tools May Help Predict 5- or 10-Year MS Disability
via Multiple Sclerosis News Today

Children with MS at Considerable Risk of Psychiatric Disorders
via Multiple Sclerosis News Today

Immune Cells Linked to Autoimmunity Found in MS Patients’ Gut
via Multiple Sclerosis News Today

Investigational Leustatin Tablets Offer Clinical Benefits to Different MS Patients
via Multiple Sclerosis News Today

Cognitive Problems in MS Patients Linked to Lower Income, Study Reports
via Multiple Sclerosis News Today

New Data Show Ocrevus Effective in Treating Primary and Relapsing MS
via Multiple Sclerosis News Today

Escalation vs. Induction Treatment for Early MS Topic of Debate
via Multiple Sclerosis News Today

Benefits of Gilenya in MS Also Appear Linked to Its Effects on B-Cells
via Multiple Sclerosis News Today

Report from Day 1 of ECTRIMS 2016 via Shift MS

Report from Day 2 of ECTRIMS 2016 via Shift MS

Report from Day 3 of ECTRIMS 2016 via Shift MS

Hot Topics at ECTRIMS 2016 with MS Nurse Karen Vernon 

To learn more about MS HOPE Foundation and to keep up with the latest MS news and research, follow us on Facebook, Twitter, and Instagram.